Zhuozhi Medical completes a 20 million RMB angel funding round, focusing on research and development of objective pain quantification assessment and treatment solutions

Funding Rounds

▤ Summary

卓知医疗 announced a 20 million RMB angel round led by Zhongguancun Capital, with Shanghai Changyao Shengbo also participating. The company was founded in 2025 and focuses on objective pain quantification assessment and treatment solutions. It plans to use the funding to develop and iterate its core platform, including dedicated EEG and signal-acquisition hardware, non-invasive spinal cord stimulation hardware, decoding algorithms, and application software. The company will also use the capital to support multicenter clinical research for its pain management system.

$ Funding

$
Amount $2.8M Total raised
□
Date September 2, 2025 Announcement date
◎
Investors - Lead investors
▥
Company - Funded company

◇ AskAI Classifications

Sectors
No sectors detected
Functions
No functions detected

▦ Linked Companies